Meitheal Pharmaceuticals, Inc.
9 active drug shortages reported by Meitheal Pharmaceuticals, Inc..
Liraglutide Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 08/19/2025
Rocuronium Bromide Injection
- Category
- Anesthesia
- Reason
- Not specified
- Updated
- 08/19/2025
Dexmedetomidine Hydrochloride Injection
- Category
- Anesthesia
- Reason
- Not specified
- Updated
- 08/19/2025
Liraglutide Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 08/19/2025
Rocuronium Bromide Injection
- Category
- Anesthesia
- Reason
- Not specified
- Updated
- 08/19/2025
Furosemide Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 08/19/2025
Furosemide Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 08/19/2025
Azacitidine Injection
- Category
- Oncology
- Reason
- Not specified
- Updated
- 08/19/2025
Furosemide Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 08/19/2025
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.